Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Quest Diagnostics Incorporated
DGX
$195.98
Name : Quest Diagnostics Incorporated
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $21,801,277,440.00
EPSttm : 8.74
finviz dynamic chart for DGX
Quest Diagnostics Incorporated
$195.98
0.60%
$1.18
DGX — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

3.54

Margin Of Safety %

10

Put/Call OI Ratio

0.43

EPS Next Q Diff

0.68

EPS Last/This Y

1.77

EPS This/Next Y

0.84

Price

195.97

Target Price

219.31

Analyst Recom

2.18

Performance Q

11.66

Upside

-1.7%

Beta

0.65

Ticker: DGX




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-02DGX210.331.040.0514656
2026-03-04DGX208.491.0412.8314670
2026-03-05DGX203.961.090.4215014
2026-03-09DGX201.511.1916.7215702
2026-03-10DGX200.881.220.3015900
2026-03-11DGX200.531.22110.8815905
2026-03-12DGX200.80.940.0113903
2026-03-17DGX198.660.934.1813937
2026-03-18DGX195.250.930.6513898
2026-03-19DGX194.130.95104.3315199
2026-03-20DGX195.390.925.0515014
2026-03-23DGX195.610.440.067635
2026-03-24DGX196.030.445.007743
2026-03-25DGX196.430.430.047697
2026-03-26DGX198.090.435.137720
2026-03-27DGX195.490.440.037786
2026-03-30DGX197.20.431.507895
2026-03-31DGX195.990.430.647924
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-02DGX210.276.8199.110.64
2026-03-03DGX208.356.8197.310.64
2026-03-04DGX208.436.8210.610.64
2026-03-05DGX204.016.8180.210.64
2026-03-06DGX199.156.8176.710.64
2026-03-09DGX201.536.8154.810.64
2026-03-10DGX200.986.8135.010.64
2026-03-11DGX200.566.8136.810.64
2026-03-12DGX200.916.8141.410.64
2026-03-13DGX199.626.8130.610.64
2026-03-17DGX198.656.8137.110.64
2026-03-18DGX195.216.8115.910.64
2026-03-19DGX194.156.810.110.64
2026-03-20DGX195.436.825.110.64
2026-03-23DGX195.576.819.010.64
2026-03-24DGX196.086.820.010.64
2026-03-25DGX196.487.219.510.64
2026-03-26DGX198.167.227.810.64
2026-03-27DGX195.517.20.310.64
2026-03-30DGX197.177.227.610.64
2026-03-31DGX195.977.29.410.64
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-02DGX-19.430.034.36
2026-03-03DGX-19.430.034.36
2026-03-04DGX-20.800.034.36
2026-03-05DGX-20.800.034.36
2026-03-06DGX-22.500.034.36
2026-03-09DGX-22.50-0.104.36
2026-03-10DGX-22.50-0.104.36
2026-03-11DGX-22.50-0.103.54
2026-03-12DGX-22.50-0.103.54
2026-03-13DGX-22.50-0.103.54
2026-03-17DGX-22.50-0.073.54
2026-03-18DGX-22.50-0.073.54
2026-03-19DGX-22.50-0.073.54
2026-03-20DGX-22.50-0.073.54
2026-03-23DGX-22.50-0.143.54
2026-03-24DGX-22.50-0.143.54
2026-03-25DGX-22.50-0.143.54
2026-03-26DGX-19.19-0.143.54
2026-03-27DGX-19.19-0.143.54
2026-03-30DGX-19.19-0.143.54
2026-03-31DGX-19.19-0.143.54
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

2.18

Avg. EPS Est. Current Quarter

2.37

Avg. EPS Est. Next Quarter

2.86

Insider Transactions

-19.19

Institutional Transactions

-0.14

Beta

0.65

Average Sales Estimate Current Quarter

2831

Average Sales Estimate Next Quarter

2959

Fair Value

216.31

Quality Score

75

Growth Score

79

Sentiment Score

77

Actual DrawDown %

8.2

Max Drawdown 5-Year %

-28.6

Target Price

219.31

P/E

22.37

Forward P/E

17.08

PEG

2.07

P/S

1.95

P/B

3.01

P/Free Cash Flow

15.84

EPS

8.76

Average EPS Est. Cur. Y​

10.64

EPS Next Y. (Est.)

11.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.95

Relative Volume

1.28

Return on Equity vs Sector %

-13.7

Return on Equity vs Industry %

2.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

9.4
DGX Healthcare
$195.98
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
14/20
Pullback
24/25
Volume
4/15
Valuation
14/20
TP/AR
3/10
Options
6/10
RSI
44.6
Range 1M
12.8%
Sup Dist
0.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
7/25
Growth
11/30
Estimates
6/20
Inst/Vol
5/15
Options
7/10
EPS Yr
8%
EPS NY
7.9%
52W%
67.8%
💎
Long-Term Value
Quality companies, undervalued
31 /100
WEAK
🟡 HOLD +20% upside
Quality
7/30
Valuation
10/30
Growth
10/25
Stability
4/10
LT Trend
0/5
Upside
+20%
Quality
75
MoS
10%
Quest Diagnostics Incorporated
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 46000
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
DGX

Latest News

Caricamento notizie per DGX
stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today
news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance
stock history DGX – Quest Diagnostics Incorporated invest stock market
stock prices DGX premarket after hours
ticker DGX fair value insiders trading